CSIMarket
 


Fibrogen Inc   (FGEN)
Other Ticker:  
 

Fibrogen Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Fibrogen Inc in the third quarter 2023?
Due to the lack of equity, it was not possible to calculate Fibrogen Inc 's return on equity (ROE) in its third quarter 2023

What is ROE?



Return On Equity (Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -294 -322 -307 -294 -362
Return On Equity (TTM) - - -879.75 % -338.94 % -250.58 %
FGEN's Total Ranking # # # # #
Equity (TTM) in Millions -137 -82 -29 -1 46
Seq. Equity Change - - - - -62.61 %
Seq. Net Income Change - - - - -

Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





FGEN Annual Return On Equity (Dec 31 2022)
2022
(Dec 31 2021)
2021
(Dec 31 2019)
2019
(Dec 31 2018)
2018
(Dec 31 2017)
2017
Total Equity in Millions -1 229 535 528 582
Y / Y Equity Change - -57.21 % 1.31 % -9.27 % 232.62 %
Net Income in Millions -294 -290 -77 -86 -126
Y / Y Net Income Change - - - - -
Return On Equity - -126.59 % -14.38 % -16.35 % -21.67 %





More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
FGEN's' Return on Equity at Yahoo Finance
FGEN's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Roe for FGEN's Competitors
Return On Equity for Fibrogen Inc 's Suppliers
Roe for FGEN's Customers




Companies with similar Return On Equity at Sep 30 2023, within Healthcare Sector ROE
Harpoon Therapeutics Inc   486.93 %
First Wave Biopharma Inc   412.15 %
Ir med Inc   304.20 %
Glucotrack Inc   277.34 %
Therapeuticsmd Inc   216.13 %
Notable Labs Ltd   184.59 %
Scynexis Inc   182.33 %
Biomx Inc   173.61 %
Halozyme Therapeutics Inc   159.73 %
Amgen Inc   129.08 %
Janone Inc   101.35 %


Date modified: 2023-11-07T13:07:54+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright Š 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com